ABT monthly performance report
Explore ABT's monthly returns, drawdown, and seasonality trends — updated every month.
ABT monthly report
—
Key takeaways
- Abbott Laboratories (ABT) closed November 2026 at $108.52, up 2.18% for the month and −16.05% over the trailing 12 months.
- Year-to-date, ABT is −13.38%, underperforming the S&P 500 which has returned +10.62% YTD.
- The stock is trading +6.76% versus its 200-day moving average ($101.65), a bullish technical signal.
- Over the past three years, ABT has underperformed the S&P 500 by −58.08%, with a relative strength index reading of 66.1.
- Win rate over the trailing 39 months stands at 56.4% — 22 positive months versus 17 negative months.
Abbott Laboratories ended November 2026 at $108.52, posting a monthly return of +2.18%. The S&P 500 returned −0.18% over the same window, leaving relative performance at +2.36%.
The current quarter stands at +9.80% (Q4 2026 (QTD)), while medium-term trend remains constructive: price is +6.76% versus the 200-day moving average ($101.65).
Year-to-date, ABT is −13.38% against SPY +10.62%, a gap of −24.01%. The stock is currently −17.81% below its 52-week high, with maximum 3-year drawdown at −41.12%.
| Period | ABT | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | +1.18% | −0.36% | +1.55% |
| 1 Week | −1.28% | +2.59% | −3.88% |
| 1 Month | +2.18% | −0.18% | +2.36% |
| 3 Months | −1.68% | −2.37% | +0.69% |
| 6 Months | +27.82% | +0.83% | +26.99% |
| YTD | −13.38% | +10.62% | −24.01% |
| 12 Months | −16.05% | +12.25% | −28.30% |
| 3 Years | +13.29% | +71.37% | −58.08% |
| Rank | Month | Return |
|---|---|---|
| #1 | Jul 2026 | +16.49% |
| #2 | Jan 2025 | +13.10% |
| #3 | Nov 2023 | +10.30% |
| #4 | Feb 2025 | +7.88% |
| #5 | Oct 2026 | +7.46% |
| Rank | Month | Return |
|---|---|---|
| #1 | Jan 2026 | −12.76% |
| #2 | Mar 2026 | −11.76% |
| #3 | Apr 2026 | −11.57% |
| #4 | Sep 2026 | −10.45% |
| #5 | Oct 2025 | −7.70% |
| Quarter | Return |
|---|---|
| Q3 2025 | −1.52% |
| Q4 2025 | −6.46% |
| Q1 2026 | −18.05% |
| Q2 2026 | −11.62% |
| Q3 2026 | +8.92% |
| Q4 2026 (QTD) | +9.80% |
| Year | Return |
|---|---|
| 2023 | +0.26% |
| 2024 | +2.76% |
| 2025 | +10.77% |
| 2026 | −13.38% |
| Metric | Value |
|---|---|
| 52-Week High | $132.03 (2025-11-18) |
| 52-Week Low | $81.97 (2026-05-11) |
| Current Price | $108.52 |
| 200-Day Moving Average | $101.65 |
| Price vs 200DMA | +6.76% |
| 3-Year Maximum Drawdown | −41.12% (2026-05-11) |
| Current Drawdown from 52W High | −17.81% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 66.1 |
| 3-Year Excess Return vs S&P 500 | −58.08% |
| RS Peak | 116.2 (Apr 2025) |
| RS Trough | 51.3 (May 2026) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was ABT's return for this report period?
ABT returned +2.18% in the latest monthly window ending 2026-11-13.
Has ABT outperformed SPY year to date?
YTD ABT: −13.38% vs SPY: +10.62%.
What is ABT's 12-month return?
−16.05% over the trailing 12 months.
Is ABT above or below its 200-day moving average?
Price is +6.76% versus 200DMA ($101.65).
What is the maximum drawdown in the 3-year window?
−41.12% on 2026-05-11.